The EU SCCS Issues Its Final Safety Opinion on Hydroxyapatite (Nano)

The EU SCCS final safety opinion on hydroxyapatite (nano) gives teams a more concrete reference point for regulatory and product evaluation.

The most useful takeaway is a more practical reference for indications, safety review, compliance judgment, and technical decision-making.

For product teams, the next step is to translate that guidance into clearer development standards, safety review, and communication with the market.